Viewing Study NCT01291667


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-28 @ 6:14 PM
Study NCT ID: NCT01291667
Status: COMPLETED
Last Update Posted: 2011-02-08
First Post: 2011-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE
Sponsor: Shanghai CP Guojian Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module